West Pharmaceutical Services SG&A Expenses 2010-2024 | WST

West Pharmaceutical Services sg&a expenses for the twelve months ending September 30, 2024 were $0.343B, a 1.69% decline year-over-year.

  • West Pharmaceutical Services annual sg&a expenses for 2023 were $0.353B, a 11.52% increase from 2022.
  • West Pharmaceutical Services annual sg&a expenses for 2022 were $0.317B, a 12.65% decline from 2021.
  • West Pharmaceutical Services annual sg&a expenses for 2021 were $0.363B, a 20.13% increase from 2020.

West Pharmaceutical Services SG&A Expenses 2010-2024 | WST

  • West Pharmaceutical Services annual sg&a expenses for 2023 were $0.353B, a 11.52% increase from 2022.
  • West Pharmaceutical Services annual sg&a expenses for 2022 were $0.317B, a 12.65% decline from 2021.
  • West Pharmaceutical Services annual sg&a expenses for 2021 were $0.363B, a 20.13% increase from 2020.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$78.2B
Becton Dickinson (BDX)$64.4B
Cardinal Health (CAH)$28.6B
Labcorp (LH)$19.8B
Cooper (COO)$19.7B
Align Technology (ALGN)$16.6B
Henry Schein (HSIC)$9.3B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.8B
CONMED (CNMD)$2.2B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$170M
Pro-Dex (PDEX)$147M